Your Location:
Home >
Browse articles >
Effect of Dingxin Recipe in Inhibiting Atherosclerosis Induced by PM2.5 by Up-regulating CD4 CD25 Foxp3 Regulatory T Cells Expression
Updated:2024-01-04
    • Effect of Dingxin Recipe in Inhibiting Atherosclerosis Induced by PM2.5 by Up-regulating CD4 CD25 Foxp3 Regulatory T Cells Expression

    • WAN Qiang , LIU Zhong-yong
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 17, Pages: 139-144(2018)
    • DOI: 10.13422/j.cnki.syfjx.20181732     

      CLC:

    Scan QR Code

  •  
  •  
  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

25

Views

58

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Dingxin Recipe Attenuates Atherosclerosis by Up-regulating PTEN Expression in ApoE Knockout Mice
Iron Homeostasis Imbalance Promotes Atherosclerosis and Therapeutic Mechanisms of Traditional Chinese Medicine
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Differentiation and Treatment of Vulnerable Atherosclerotic Plaque Based on "Collateral Disease" Theory
Effect and Molecular Mechanisms of Danlou Tablet on Hepatic Lipid Deposition in ApoE-/- Atherosclerotic Mice Through Regulation of SIRT6/CREB/Nor1 Signaling Pathway-mediated Autophagy

Related Author

ZHANG Yu
CHENG Sai-bo
ZHAO Dan-dan
SU Zhi-jie
ZHANG Lei
XU Yu-ling
ZHOU Feng-hua
JIA Yu-hua

Related Institution

Jiangxi University of Chinese Medicine
The Affiliated Hospital of Jiangxi University of Chinese Medicine
School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.